{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:38:17Z","timestamp":1793147897310,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["300153"],"award-info":[{"award-number":["300153"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.chest.2026.07.5002","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:59:53Z","timestamp":1784246393000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Real-World Effectiveness of Adjuvanted RSVPreF3 Vaccination in the Prevention of Respiratory Syncytial Virus-Related Hospitalization Among US Adults 60 Years of Age and Older"],"prefix":"10.1016","author":[{"given":"David","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-8961","authenticated-orcid":false,"given":"Elizabeth M.","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami R.","family":"Buikema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-7134","authenticated-orcid":false,"given":"Emily K.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Theiss-Nyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan I.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary G.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Bradley","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.chest.2026.07.5002_bib2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.chest.2026.07.5002_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","article-title":"Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices\u2014United States","volume":"72","author":"Melgar","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.chest.2026.07.5002_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2026.07.5002_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1473-3099(24)00796-5","article-title":"Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study","volume":"25","author":"Bajema","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.chest.2026.07.5002_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8322","article-title":"Effectiveness and safety of respiratory syncytial virus vaccine for US adults aged 60 years or older","volume":"8","author":"Fry","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"13","key":"10.1016\/j.chest.2026.07.5002_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jama.2024.15775","article-title":"RSV vaccine effectiveness against hospitalization among US adults 60 years and older","volume":"332","author":"Surie","year":"2024","journal-title":"JAMA"},{"issue":"10462","key":"10.1016\/j.chest.2026.07.5002_bib9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(24)01738-0","article-title":"Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis","volume":"404","author":"Payne","year":"2024","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.chest.2026.07.5002_bib11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/jama.2022.17876","article-title":"Association of primary and booster vaccination and prior infection with SARS-CoV-2 infection and severe COVID-19 outcomes","volume":"328","author":"Lin","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.chest.2026.07.5002_bib12","article-title":"Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: a retrospective cohort study","volume":"9","author":"Tartof","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"5","key":"10.1016\/j.chest.2026.07.5002_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0320434","article-title":"Effectiveness over time of a primary series of the original monovalent COVID-19 vaccines in adults in the United States","volume":"20","author":"Layton","year":"2025","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.chest.2026.07.5002_bib14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.chest.2026.07.5002_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.chest.2026.07.5002_bib16","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.chest.2026.07.5002_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score","volume":"39","author":"Rosenbaum","year":"1985","journal-title":"Am Statist"},{"key":"10.1016\/j.chest.2026.07.5002_bib18","series-title":"Clinical Classification Software (CCS) for ICD-9-CM","year":"2025"},{"issue":"12","key":"10.1016\/j.chest.2026.07.5002_bib19","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/aje\/kwad151","article-title":"Translation of a claims-based frailty index from the International Classification of Diseases, Ninth Revision, clinical modification to the tenth revision","volume":"192","author":"Duchesneau","year":"2023","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.chest.2026.07.5002_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pds.3719","article-title":"Using claims data to predict dependency in activities of daily living as a proxy for frailty","volume":"24","author":"Faurot","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.chest.2026.07.5002_bib21","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3201\/eid2608.191493","article-title":"Analysis of MarketScan data for immunosuppressive conditions and hospitalizations for acute respiratory illness, United States","volume":"26","author":"Patel","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"187","key":"10.1016\/j.chest.2026.07.5002_bib22","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/aje\/kwy049","article-title":"Relative performance of propensity score matching strategies for subgroup analyses","volume":"1","author":"Wang","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.chest.2026.07.5002_bib23","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1177\/09622802231188517","article-title":"Propensity score weighting methods for causal subgroup analysis with time-to-event outcomes","volume":"32","author":"Yang","year":"2023","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.chest.2026.07.5002_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.919223","article-title":"Respiratory tract infections in diabetes\u2014lessons from tuberculosis and influenza to guide understanding of COVID-19 severity","volume":"13","author":"Al-Sayyar","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.chest.2026.07.5002_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf394","article-title":"Respiratory syncytial virus risk assessment in adults: implications for vaccine recommendations beyond age","volume":"12","author":"Branche","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2026.07.5002_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2535755","article-title":"RSV vaccination uptake among adults aged 60 years and older in the United States during the 2023-2025 vaccination seasons","volume":"21","author":"La","year":"2025","journal-title":"Hum Vaccin Immunother"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922605974X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922605974X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:34:23Z","timestamp":1788550463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236922605974X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"alternative-id":["S001236922605974X"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2026.07.5002","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Effectiveness of Adjuvanted RSVPreF3 Vaccination in the Prevention of Respiratory Syncytial Virus-Related Hospitalization Among US Adults 60 Years of Age and Older","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2026.07.5002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 GSK plc. Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}